| Date Initiated by Firm | October 11, 2017 |
| Create Date | October 11, 2018 |
| Recall Status1 |
Terminated 3 on November 09, 2020 |
| Recall Number | Z-0074-2018 |
| Recall Event ID |
78288 |
| 510(K)Number | K952095 |
| Product Classification |
Gram positive identification panel - Product Code LQL
|
| Product | VITEK2 GP-ID, REF 21342 IVD |
| Code Information |
UDI 03573026131920, Lot Number 2420348103 |
| FEI Number |
1950204
|
Recalling Firm/ Manufacturer |
Biomerieux Inc
595 Anglum Rd
Hazelwood
MO
63042-2320
|
| For Additional Information Contact | 314-731-8526 |
Manufacturer Reason for Recall | Customers have reported, and an internal investigation has confirmed, occurrences of atypical negative O129R reactions for Enterococcus casseliflavus ATCC)R) 700327(TM) in association with three (3) VITEK(R) 2 GP ID Lots, causing failure of the Quality Control (QC) testing for the VITEK(R) 2 GP ID card. In accordance with the VITEK(R) 2 GP ID Instructions For Use, the expected O129R reaction for ATCC(R) 700327(TM) strain is positive. As a precaution, bioMrieux is also including in the scope of this notice all GP ID card lots manufactured with the same raw materials. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | Consignees (Subsidiaries) of bioMrieux, impacted by the identified issue, were notified of the FSCA and corrective action (FSCA notification) electronically on 10/11/2017. The direct consignees (subsidiaries and distributors) have until 11/11/2017 to notify their respective impacted users. The directions to the user are as follows: "Please implement the following actions at this time: We request you take the following action at this time: " Please confirm this letter has been distributed and reviewed by all appropriate personnel within your
organization. " Please refrain from using the referenced test kits (VITEK 2 GP ID, Lots 2420240403, 2420303403, and 2420348103) in your laboratory. Destroy any of this product in your inventory, and contact your local bioMrieux
representative for credit or replacement. " Please store this letter with your bioMrieux system documentation. "Complete the attached Acknowledgement Form and return it to your local bioMrieux representative." |
| Quantity in Commerce | 5672 cartons |
| Distribution | worldwide |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|
| 510(K) Database | 510(K)s with Product Code = LQL
|